Bio-Gate AG (FRA:BIG1)

Bio-Gate AG Statistics

Total Valuation

Bio-Gate AG has a market cap or net worth of EUR 7.30 million. The enterprise value is 7.57 million.

Market Cap	7.30M
Enterprise Value	7.57M

Important Dates

The next estimated earnings date is Thursday, December 11, 2025.

Earnings Date	Dec 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Bio-Gate AG has 9.24 million shares outstanding.

Current Share Class	9.24M
Shares Outstanding	9.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.04
PB Ratio	7.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.49
EV / Sales	1.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.21

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.47.

Current Ratio	1.81
Quick Ratio	0.41
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-0.59
Interest Coverage	-22.98

Financial Efficiency

Return on equity (ROE) is -87.83% and return on invested capital (ROIC) is -41.61%.

Return on Equity (ROE)	-87.83%
Return on Assets (ROA)	-20.00%
Return on Invested Capital (ROIC)	-41.61%
Return on Capital Employed (ROCE)	-49.11%
Revenue Per Employee	151,993
Profits Per Employee	-29,963
Employee Count	45
Asset Turnover	1.63
Inventory Turnover	1.84

Taxes

In the past 12 months, Bio-Gate AG has paid 96 in taxes.

Income Tax	96
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.54% in the last 52 weeks. The beta is 0.30, so Bio-Gate AG's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-50.54%
50-Day Moving Average	1.36
200-Day Moving Average	1.39
Relative Strength Index (RSI)	58.20
Average Volume (20 Days)	1,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio-Gate AG had revenue of EUR 6.99 million and -1.38 million in losses. Loss per share was -0.15.

Revenue	6.99M
Gross Profit	4.03M
Operating Income	-1.37M
Pretax Income	-1.44M
Net Income	-1.38M
EBITDA	-1.07M
EBIT	-1.37M
Loss Per Share	-0.15

Balance Sheet

The company has 174,370 in cash and 435,000 in debt, giving a net cash position of -260,630 or -0.03 per share.

Cash & Cash Equivalents	174,370
Total Debt	435,000
Net Cash	-260,630
Net Cash Per Share	-0.03
Equity (Book Value)	916,469
Book Value Per Share	0.10
Working Capital	1.11M

Cash Flow

In the last 12 months, operating cash flow was -715,000 and capital expenditures -26,000, giving a free cash flow of -741,000.

Operating Cash Flow	-715,000
Capital Expenditures	-26,000
Free Cash Flow	-741,000
FCF Per Share	-0.08

Margins

Gross margin is 57.61%, with operating and profit margins of -19.65% and -19.71%.

Gross Margin	57.61%
Operating Margin	-19.65%
Pretax Margin	-20.53%
Profit Margin	-19.71%
EBITDA Margin	-15.27%
EBIT Margin	-19.65%
FCF Margin	n/a

Dividends & Yields

Bio-Gate AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-18.87%
FCF Yield	-10.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 26, 2012
Split Type	Reverse
Split Ratio	0.25

Scores

Bio-Gate AG has an Altman Z-Score of -2.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.53
Piotroski F-Score	3